Overview

Myositis, including polymyositis, immune-mediated necrotizing myopathy, antisynthetase syndrome, dermatomyositis, and inclusion body myositis, represents a group of rare inflammatory muscle diseases that significantly impact patient quality of life due to chronic muscle weakness, pain, and systemic complications. Despite advancements in the understanding of myositis pathophysiology, rheumatologists face challenges in the early and accurate diagnosis and management of these conditions, often resulting in delayed treatment and suboptimal outcomes.

Our distinguished panel of national experts will discuss evidence-based guidelines for myositis, particularly in the integration of novel biomarkers, imaging techniques, immunosuppressive agents, and emerging targeted therapies. We will also cover how to identify and manage systemic complications associated with myositis, including interstitial lung disease, dysphagia, chronic weakness, and cutaneous manifestations of myositis, through a multidisciplinary approach.

Target Audience

This activity is targeted to rheumatologists, residents, and fellows.

Learning Objectives

HSS continuing medical education activities are intended to improve the quality of patient care and safety. At the completion of the course, the participant should be able to:

• Recognize clinical differences and key features of archetypal presentations of different forms of myositis, as well as of key clinical mimics of myositis, to utilize biomarkers and advanced imaging to improve the early detection and differentiation of various forms of myositis.
• Evaluate and implement evidence-based treatment strategies, including the use of immunosuppressive agents and emerging targeted therapies, to optimize patient outcomes in myositis.
• Identify and manage systemic complications associated with myositis, including interstitial lung disease, dysphagia, chronic weakness, and cutaneous manifestations of myositis, through a multidisciplinary approach.
• Critically assess recent clinical trials and research findings to inform clinical decision-making and enhance patient-centered care in myositis.

Accreditation and Credit Designation

Hospital for Special Surgery is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Hospital for Special Surgery designates this live activity for a maximum of 6.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 6.00 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

For more information please visit the official event page.